Issues to Consider in Liquid Extraction Testing of Surfaces for Particulate Matter

Area of Science:

• Pharmaceutical manufacturing
• Surface science
• Analytical chemistry

Background:

• Pharmaceutical manufacturing involves contact between formulation ingredients, process fluids, and drug products with various material surfaces.
• Good manufacturing practice (cGMP) mandates control of surface cleanliness to meet particulate matter requirements in final drug products.
• Aseptic processes, like cell therapy, may not allow filtration, leading to particulate matter accumulation and risks to drug purity.

Purpose of the Study:

• To address challenges in measuring surface cleanliness using liquid extraction.
• To discuss methods for assessing and reporting surface cleanliness in pharmaceutical manufacturing.
• To provide essential data for risk assessments related to particulate matter on contact surfaces.

Main Methods:

• Liquid extraction techniques for sampling particulate matter from contact surfaces.
• Quantitative measurement of particulate matter.
• Development of approaches for assessing and reporting surface cleanliness data.

Main Results:

• Identified issues and challenges associated with the liquid extraction method for surface cleanliness measurement.
• Proposed approaches for assessing and reporting surface cleanliness data.
• Highlighted the importance of quantitative measurement for risk assessment.

Conclusions:

• Accurate measurement of surface cleanliness is essential for ensuring drug product purity, particularly in aseptic manufacturing.
• Liquid extraction presents challenges that need to be addressed for reliable surface cleanliness assessment.
• Standardized approaches to assessing and reporting surface cleanliness are needed for effective risk management in pharmaceutical production.